New Delhi: Sputnik V will be made by another Indian pharmaceutical firm Virchow Biotech Private Limited, which will be the 5th partnership for making the vaccine in India.
It will manufacture 200 million vaccine doses per year.
The Russian vaccine has an efficacy of 91.6 per cent.
“Vaccine partnerships are the only way to overcome the pandemic. The world continues its fight against coronavirus and we see a growing interest in Sputnik V vaccine as it is one of the most efficient vaccines available. The agreement with Virchow Biotech is an important step to facilitate the full-scale local production of the vaccine in India and to supply our international partners globally,” said chief executive officer of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev.
Sputnik V was the world’s first registered vaccine against COVID-19.
RDIF on Friday had announced its partnership with Stelis Biopharma Pvt Ltd to make 200 million doses here. Dr Reddy’s is already making the vaccine in India. Two other Hyderabad-based players, Hetero and Gland Pharma, will be supplying 100 million and 252 million vaccine doses respectively. The vaccine is likely to be approved in India soon.
